NASDAQHealth CareHealth Information ServicesSnapshot 2026-07-23
Reading HSTM? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a stable management team. The current thesis is intact, supported by strong recent financial performance and a commitment to returning value to shareholders.
The market currently reflects a neutral valuation, with a slight premium compared to peers. However, this premium may not fully account for the potential risks and uncertainties in the sector.
Fundamentals are expected to remain strong, driven by robust earnings quality and a stable management approach. There is a low probability of missing guidance, but the company is still a smaller-cap name, which carries some inherent risk.
The thesis hinges on the company's ability to reaffirm its full-year guidance and the performance of sector bellwethers like VEEV, BTSG, and TEM. Any changes in their earnings or guidance could significantly impact HSTM's trajectory.
In the next 1 to 3 years, HSTM's performance will depend on its ability to navigate sector dynamics and maintain its guidance. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improvement, indicating strong financial performance. There are no current threats to the thesis, suggesting a stable outlook for the company.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: The earnings report will show how well the company is meeting its full-year guidance after a recent miss.
Confirms one read:Q2 earnings meet or exceed the full-year guidance reaffirmed in May 2026.
Confirms the other:Q2 earnings miss again, raising doubts about the full-year guidance.
Why it matters: Hitting this growth target shows strong progress. It matches the full-year goals.
Confirms:Q2 revenue growth of 10% or more compared to Q2 2025.
Disproves:Q2 revenue growth falls below 5% compared to Q2 2025.
Why it matters: Raising dividends shows strong financial health. It also shows a commitment to shareholders.
Confirms:The company announces an increase in the quarterly dividend from $0.035 per share.
Disproves:The company maintains the dividend at $0.035 per share without an increase.
Why it matters: Completing the share buyback shows management trusts the company's value and future.
Confirms:The share buyback program ends by the September 12, 2026 deadline.
Disproves:The program is suspended or not completed by the September 12, 2026 deadline.
Why it matters: This shows strong performance and backs the company's growth story.
Confirms:Q2 2026 adjusted EBITDA meets or exceeds $20 million.
Disproves:In Q2 2026, adjusted EBITDA drops below $18 million.
Why it matters: A drop in revenue growth below its median could signal challenges in the growth phase.
Confirms:Revenue growth drops below the median growth rate for the sector.
Disproves:If revenue growth is steady or goes up, it supports the growth story.
Why it matters: Completing the share buyback shows strong cash flow. It also shows a commitment to shareholders.
Confirms:The company will finish the $10 million share buyback by September 2026.
Disproves:The company may stop or change the share buyback plan before it is done.
Why it matters: More buybacks show good cash flow. They also show a promise to give value to shareholders.
Confirms:Announcement of a new share repurchase program or an extension of the current one.
Disproves:No new news on share buybacks before the next earnings call.
Why it matters: An increase shows strong financial health. It also shows a promise to return money to shareholders.
Confirms:Announcement of a dividend increase above $0.035 per share.
Disproves:Dividend remains at $0.035 per share or decreases.
